Coherus BioSciences: Q1 Earnings Snapshot

REDWOOD CITY, Calif. (AP) _ Coherus BioSciences Inc. (CHRS) on Thursday reported a first-quarter loss of $172.9 million, after reporting a profit in the same period a year earlier.

The Redwood City, California-based company said it had a loss of $2.37 per share.

The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for earnings of 9 cents per share.

The drug developer posted revenue of $83 million in the period, which also missed Street forecasts. Three analysts surveyed by Zacks expected $97.9 million.

Coherus BioSciences shares have dropped 17% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $14.50, a fall of 10% in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CHRS at https://www.zacks.com/ap/CHRS